Skip to content
Medium cut-off hemodialysis in multiple myeloma-associated cast nephropathy: A single-center experience
All contributors

Onconephrology contributor

Zheng, Junnian

Primarily Cellular therapy renal effects#45 of 47 recognized
  • #4 in Cellular therapy renal effects
10
Clinical papers
321
Citations (iCite)
0 / 3
First / senior author
2017–2026
Active years

Output over time

Clinical corpus papers per year — peak 2 in 2018.

  • 2017: 1 paper
  • 2018: 2 papers
  • 2020: 2 papers
  • 2021: 2 papers
  • 2024: 1 paper
  • 2025: 1 paper
  • 2026: 1 paper
20172026

Subfield mix

Clinical papers by onconephrology subfield (a paper can count in more than one).

Cellular therapy renal effects10
Myeloma cast nephropathy2

Verify

Representative recent papers, and this author’s full PubMed bibliography.

PMID 41501787 (opens PubMed in a new tab)PMID 40310507 (opens PubMed in a new tab)PMID 39368372 (opens PubMed in a new tab)PMID 34734474 (opens PubMed in a new tab)PMID 34411731 (opens PubMed in a new tab)PMID 32388534 (opens PubMed in a new tab)All papers on PubMed

A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,329-article corpus (regenerated 2026-08-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.